Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isao Sakaida

Showing results (11-20 of 332) with videos related to

Pageof 34
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 16, 2012
Evaluation of a novel non-invasive (13) C-glucose breath test for the identification of diabetes mellitus in cirrhotic patientsMasako Tsuchiya, Takahiro Yamasaki, Isao Sakaida
Oncology|March 1, 2002
Current strategies for chemoprevention of hepatocellular carcinomaKiwamu Okita, Isao Sakaida, Keisuke Hino
Journal of Gastroenterology|August 3, 2007
The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosisHaiyan Jin, Shuji Terai, Isao Sakaida
Expert Review of Gastroenterology & Hepatology|December 23, 2015
Cell transplantation as a non-invasive strategy for treating liver fibrosisToshihiko Matsumoto, Taro Takami, Isao Sakaida
Internal Medicine (Tokyo, Japan)|June 28, 2019
Efficacy of Vonoprazan for Helicobacter pylori EradicationShu Kiyotoki, Jun Nishikawa, Isao Sakaida
Discovery Medicine|August 1, 2012
Advanced therapies using autologous bone marrow cells for chronic liver diseaseTaro Takami, Shuji Terai, Isao Sakaida
Current Opinion in Gastroenterology|March 8, 2012
Stem cell therapy in chronic liver diseaseTaro Takami, Shuji Terai, Isao Sakaida
Journal of Pharmacological Sciences|February 26, 2011
Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patientsTaro Takami, Shuji Terai, Isao Sakaida
Hepatology International|July 24, 2015
Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatmentsTakahiro Yamasaki, Issei Saeki, Isao Sakaida
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 18, 2005
The effect of a late evening snack in patients with liver cirrhosisMasako Tsuchiya, Isao Sakaida, Mariko Okamoto, et al.
Pageof 34

Showing results (11-20 of 332) with videos related to

Sort By:
Pageof 34
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 16, 2012
Evaluation of a novel non-invasive (13) C-glucose breath test for the identification of diabetes mellitus in cirrhotic patientsMasako Tsuchiya, Takahiro Yamasaki, Isao Sakaida
Oncology|March 1, 2002
Current strategies for chemoprevention of hepatocellular carcinomaKiwamu Okita, Isao Sakaida, Keisuke Hino
Journal of Gastroenterology|August 3, 2007
The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosisHaiyan Jin, Shuji Terai, Isao Sakaida
Expert Review of Gastroenterology & Hepatology|December 23, 2015
Cell transplantation as a non-invasive strategy for treating liver fibrosisToshihiko Matsumoto, Taro Takami, Isao Sakaida
Internal Medicine (Tokyo, Japan)|June 28, 2019
Efficacy of Vonoprazan for Helicobacter pylori EradicationShu Kiyotoki, Jun Nishikawa, Isao Sakaida
Discovery Medicine|August 1, 2012
Advanced therapies using autologous bone marrow cells for chronic liver diseaseTaro Takami, Shuji Terai, Isao Sakaida
Current Opinion in Gastroenterology|March 8, 2012
Stem cell therapy in chronic liver diseaseTaro Takami, Shuji Terai, Isao Sakaida
Journal of Pharmacological Sciences|February 26, 2011
Novel findings for the development of drug therapy for various liver diseases: Current state and future prospects for our liver regeneration therapy using autologous bone marrow cells for decompensated liver cirrhosis patientsTaro Takami, Shuji Terai, Isao Sakaida
Hepatology International|July 24, 2015
Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatmentsTakahiro Yamasaki, Issei Saeki, Isao Sakaida
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 18, 2005
The effect of a late evening snack in patients with liver cirrhosisMasako Tsuchiya, Isao Sakaida, Mariko Okamoto, et al.
Pageof 34